In a study on FGFR1 analyses regarding gene copy number and its relationship with clinicopathological parameters among ER-positive/HER2-negative primary breast cancer, a high level of FGFR1 expression was detected in about one-fourth of the subjects. This evidence concerns the gene ERBB2 and breast carcinoma.